Details for Patent: 6,024,978

Summary for Patent: 6,024,978

Patent landscape, scope, and claims:

Title:	Pharmaceutical compositions comprising cyclosporins
Abstract:	Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
Inventor(s):	Hauer; Birgit (Lahr, DE), Meinzer; Armin (Munzingen, DE), Posanski; Ulrich (Freiburg, DE), Richter; Friedrich (Urtenen, CH)
Assignee:	Novartis AG (Basel, CH)
Application Number:	09/184,546
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 6,024,978

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,024,978

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	8821754	Sep 16, 1988
United Kingdom	8902900	Feb 09, 1989
United Kingdom	8902903	Feb 09, 1989

International Family Members for US Patent 6,024,978

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	403435
Austria	A214289
Australia	4140089